Form D · Biotechnology
Neuros Medical, Inc.
Aliso Viejo, CA · CIK 0001474720
Offering snapshot reported Aug 6, 2025 · SEC filing
- Reported sold
- $56M Offering amount: $65M
- Investors reported
- 28 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 9, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 6, 2025 | Initial | $55,999,997 | No comparison | 28 | SEC filing |
| Sep 25, 2023 | Initial | $20,000,000 | No comparison | 41 | SEC filing |
| Dec 19, 2022 | Initial | $8,229,699 | No comparison | 40 | SEC filing |
| Nov 3, 2020 | Initial | $36,981,418 | No comparison | 24 | SEC filing |
| Jun 10, 2020 | Initial | $2,200,000 | No comparison | 5 | SEC filing |
| Oct 22, 2019 | Initial | $2,385,759 | No comparison | 4 | SEC filing |
| Aug 16, 2017 | Initial | $22,634,257 | No comparison | 27 | SEC filing |
| Aug 16, 2017 | Initial | $0 | No comparison | 55 | SEC filing |
| May 12, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 19, 2013 | Initial | $1,750,000 | No comparison | 11 | SEC filing |
| Feb 11, 2013 | Amendment | $2,508,310 | $0vs Jun 7, 2012 | 29 | SEC filing |
| Jun 7, 2012 | Initial | $2,508,310 | No comparison | 25 | SEC filing |
| Oct 19, 2009 | Initial | $1,285,029 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-553915
Source: Form D, filed Aug 6, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Fouad Azzam | Director |
| Randy Ban | Director |
| Robert J. Centa | Executive |
| Scott F. Drees | Director |
| Joyce Erony | Director |
| William Harrington | Director |
| Stephen R. Haynes | Director |
| Joseph J. Jankowski | Director |
| Alan Kaganov | Director |
| Marc Andre Marcotte | Director |
| Anthony Natale | Director |
| Claiborne R. Rankin | Director |
| Jon J. Snyder | Director, Executive |
| Zach Stassen | Executive |
| Casey Tansey | Director |
| Mark W. Teague | Executive |
| David Veino | Director, Executive |
| Thomas C. Wilder | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
26800 Aliso Viejo Pkwy, Suite 250
Aliso Viejo, CA, 92656
Aliso Viejo, CA, 92656